BTMD - biote Corp

2.2
-0.010   -0.455%

Share volume: 315,192
Last Updated: 05-12-2026
Pharmaceutical Products/Medicinal Chemicals: 0.85%

PREVIOUS CLOSE
CHG
CHG%
$2.21
-0.01
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
89%
Profitability 100%
Dept financing 50%
Liquidity 41%
Performance 100%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
0.92%
1 Month
22.91%
3 Months
3.29%
6 Months
-15.38%
1 Year
-43.73%
2 Year
-63.39%
Key data
Stock price
$2.20
P/E Ratio 
N/A
DAY RANGE
$2.10 - $2.25
EPS 
$1.10
52 WEEK RANGE
$1.27 - $4.75
52 WEEK CHANGE
-$44.16
MARKET CAP 
0.000
YIELD 
N/A
SHARES OUTSTANDING 
39.551 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-06-2025
BETA 
1.02
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$226,574
AVERAGE 30 VOLUME 
$206,222
Company detail
CEO: Terry S. Weber
Region: US
Website: biote.com
Employees: 0
IPO year: 2021
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Medicinal Chemicals
Sector: Manufacturing

Haymaker Acquisition Corp. III does not have any significant operations. The company was incorporated in 2020 and is based in New York, New York.

Recent news